Casy Burnsed is the founder and operator of Trillium Meds, an Oregon-based telehealth access platform focused on transparent, patient-first access to compounded GLP-1 medications. Trillium Meds connects patients nationwide with licensed medical providers and regulated U.S. compounding pharmacies, with an emphasis on clear pricing, realistic expectations, and ethical telehealth practices. Burnsed’s work centers on demystifying how telehealth platforms, provider networks, and pharmacy fulfillment actually function, particularly in a market where pricing and processes are often opaque to consumers. He regularly advises on GLP-1 cost structures, medication fulfillment timelines, telehealth compliance considerations, and patient education. Prior to founding Trillium Meds, Burnsed worked in e...